Microbiota transplantation demonstrates how gut bacteria contributes to weight loss and beneficial metabolic effects with gelesis' proprietary hydrogel

Boston--(business wire)--gelesis (nyse: gls), the maker of plenity for weight management, presented new preclinical data showing weight loss and additional metabolic benefits in mice receiving a microbiota transplant from another group of mice, treated with one of the company's proprietary hydrogels. these metabolic benefits occurred while both groups of mice, the donors of the microbiota transplant and the recipient mice, were on a high fat, high carbohydrate diet typically causing rapid weigh
GLS Ratings Summary
GLS Quant Ranking